Literature DB >> 12770792

TNF and TNF receptor polymorphisms in Korean Behcet's disease patients.

Eun Bong Lee1, Jeong Yeon Kim, Yun Jong Lee, Myoung Hee Park, Yeong Wook Song.   

Abstract

Behcet's disease (BD) is an autoimmune disease characterized by recurrent oral ulcers, genital ulcers, erythema nodosum, and uveitis. Genetic factors are considered important in its pathogenesis. The serum level of tumor necrosis factor (TNF) is elevated in patients with active BD, and its production is elevated in monocytes and in the gamma delta T cells of BD patients. A dramatic response to anti-TNF-alpha antibody treatment further supports the role of TNF in BD. In this study, we investigated genetic polymorphisms of TNF alpha -308 G/A, TNF beta +252 G/A, and TNFR2 196 R/M in 94 Korean BD patients and age- and sex-matched healthy controls to investigate the role of TNF and TNF receptor polymorphisms in BD. The polymerase chain reaction-restriction fragment length polymorphism was used to identify the TNF-alpha promoter (G = TNFA1, A = TNFA2) and TNF-beta intron polymorphisms (G = TNFB1, A = TNFB2), and polymerase chain reaction-singly-strand conformation polymorphism was used to identify TNFR2 196R/M polymorphism (T = TNFR2M, G = TNFR2R). No differences were found in the TNF-alpha, TNF-beta or TNFR2 polymorphisms of the patients and the healthy controls. The allele frequencies of TNFA1/A2 were 0.94/0.06 in patients and 0.96/0.04 in healthy controls (p = 0.36, OR = 0.65, 95% CI = 0.26-1.63), for TNFB1/TNFB2 these were 0.42/0.58 in patients and 0.44/0.56 in controls (p = 0.68, OR = 0.91, 95% CI = 0.61-1.38), and for TNFR2R/TNFR2M 0.23/0.77 in patients and 0.21/0.79 in controls (p = 0.62, OR = 1.13, 95% CI = 0.69-1.84). In conclusion, this study found no differences of TNF alpha -308 G/A, TNF beta +252 G/A or of the TNFR2 196R/M polymorphisms in Korean BD patients versus healthy controls. These findings suggest that the role of TNF in BD is not genetically determined, but can be functionally explained.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12770792     DOI: 10.1016/s0198-8859(03)00057-0

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  15 in total

1.  Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease.

Authors:  H Nagafuchi; M Takeno; H Yoshikawa; M S Kurokawa; K Nara; E Takada; C Masuda; M Mizoguchi; N Suzuki
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

2.  [Clinical analysis of golimumab in the treatment of severe/refractory cardiovascular involvement in Behcet syndrome].

Authors:  L X Sun; J J Liu; Y X Hou; C R Li; L Li; X P Tian; X F Zeng; W J Zheng
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

3.  SUMO4 C438T polymorphism is associated with papulopustular skin lesion in Korean patients with Behçet's disease.

Authors:  Geon Park; Hyun-Sook Kim; Jung-Yoon Choe; Seong-Kyu Kim
Journal:  Rheumatol Int       Date:  2011-09-08       Impact factor: 2.631

4.  Analyses of functional IL10 and TNF-α genotypes in Behçet's syndrome.

Authors:  Omer Ateş; Levent Dalyan; Gulen Hatemi; Vedat Hamuryudan; Aysegul Topal-Sarıkaya
Journal:  Mol Biol Rep       Date:  2010-02-27       Impact factor: 2.316

Review 5.  Cytokines in autoimmune uveitis.

Authors:  Reiko Horai; Rachel R Caspi
Journal:  J Interferon Cytokine Res       Date:  2011-07-25       Impact factor: 2.607

6.  Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Behçet's disease.

Authors:  Aşkin Ateş; Gülay Kinikli; Nurşen Düzgün; Murat Duman
Journal:  Rheumatol Int       Date:  2005-05-05       Impact factor: 2.631

7.  TNF-alpha gene polymorphisms in Iranian Azeri Turkish patients with Behcet's Disease.

Authors:  Mortaza Bonyadi; Zohreh Jahanafrooz; Mohsen Esmaeili; Susan Kolahi; Alireza Khabazi; Ali Asghar Ebrahimi; Mehrzad Hajialilo; Saeed Dastgiri
Journal:  Rheumatol Int       Date:  2009-09-23       Impact factor: 2.631

8.  Association of TNFA promoter region haplotype in Behçet's Disease.

Authors:  KyungSook Park; NaYoung Kim; JungHyun Nam; Dongsik Bang; Eun-So Lee
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

Review 9.  HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies.

Authors:  Mathilde de Menthon; Michael P Lavalley; Carla Maldini; Loïc Guillevin; Alfred Mahr
Journal:  Arthritis Rheum       Date:  2009-10-15

10.  T helper 1 type cytokines polymorphisms: association with susceptibility to Behçet's disease.

Authors:  Gamze Alayli; Fatma Aydin; Ahmet Yilmaz Coban; Yüksel Süllü; Ferhan Cantürk; Yüksel Bek; Belma Durupinar; Tayyar Cantürk
Journal:  Clin Rheumatol       Date:  2007-01-09       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.